{"id":"https://openalex.org/W2999588368","doi":"https://doi.org/10.1038/s41419-020-2223-8","title":"Improvement of epidermal covering on AEC patients with severe skin erosions by PRIMA-1MET/APR-246","display_name":"Improvement of epidermal covering on AEC patients with severe skin erosions by PRIMA-1MET/APR-246","publication_year":2020,"publication_date":"2020-01-16","ids":{"openalex":"https://openalex.org/W2999588368","doi":"https://doi.org/10.1038/s41419-020-2223-8","mag":"2999588368","pmid":"https://pubmed.ncbi.nlm.nih.gov/31949132","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6965199"},"language":"en","primary_location":{"id":"doi:10.1038/s41419-020-2223-8","doi":"https://doi.org/10.1038/s41419-020-2223-8","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41419-020-2223-8","pdf_url":"https://www.nature.com/articles/s41419-020-2223-8.pdf","source":{"id":"https://openalex.org/S185208586","display_name":"Cell Death and Disease","issn_l":"2041-4889","issn":["2041-4889"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Death & Disease","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41419-020-2223-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031276936","display_name":"\u00c9dith Aberdam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]},{"id":"https://openalex.org/I4387154437","display_name":"HIPI -  Immunologie humaine, physiopathologie et immunith\u00e9rapie","ror":"https://ror.org/008e1sp22","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154437"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Edith Aberdam","raw_affiliation_strings":["INSERM U976, Paris, France","Universit\u00e9 Paris-Diderot, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U976, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154437"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Diderot, Paris, France","institution_ids":["https://openalex.org/I4387154366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067860973","display_name":"Lauriane N. Roux","orcid":"https://orcid.org/0000-0002-4343-3004","observed_orcids":["https://orcid.org/0000-0002-4343-3004"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]},{"id":"https://openalex.org/I4387154437","display_name":"HIPI -  Immunologie humaine, physiopathologie et immunith\u00e9rapie","ror":"https://ror.org/008e1sp22","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154437"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lauriane N. Roux","raw_affiliation_strings":["INSERM U976, Paris, France","Universit\u00e9 Paris-Diderot, Paris, France"],"raw_orcid":"https://orcid.org/0000-0002-4343-3004","affiliations":[{"raw_affiliation_string":"INSERM U976, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154437"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Diderot, Paris, France","institution_ids":["https://openalex.org/I4387154366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075779028","display_name":"Philippe-Henri Secr\u00e9tan","orcid":"https://orcid.org/0000-0002-5838-3695","observed_orcids":["https://orcid.org/0000-0002-5838-3695"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4405256918","display_name":"Mat\u00e9riaux et sant\u00e9","ror":"https://ror.org/04p1n4n05","country_code":"FR","type":"facility","lineage":["https://openalex.org/I277688954","https://openalex.org/I4405256918","https://openalex.org/I4405278506"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe-Henri Secr\u00e9tan","raw_affiliation_strings":["Department of Pharmacy, H\u00f4pital Universitaire Necker-Enfants Malades, Paris, F-75006, France","Facult\u00e9 de Pharmacie, EA 401, Universit\u00e9 Paris Sud, Chatenay-Malabry, F-92290, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, H\u00f4pital Universitaire Necker-Enfants Malades, Paris, F-75006, France","institution_ids":["https://openalex.org/I1288880153"]},{"raw_affiliation_string":"Facult\u00e9 de Pharmacie, EA 401, Universit\u00e9 Paris Sud, Chatenay-Malabry, F-92290, France","institution_ids":["https://openalex.org/I102197404","https://openalex.org/I4405256918"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084913969","display_name":"F. Boral\u00e9vi","orcid":"https://orcid.org/0000-0002-0477-5909","observed_orcids":["https://orcid.org/0000-0002-0477-5909"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]},{"id":"https://openalex.org/I4210112727","display_name":"H\u00f4pital Pellegrin","ror":"https://ror.org/02x581406","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443","https://openalex.org/I4210112727"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Franck Boralevi","raw_affiliation_strings":["Pediatric Dermatology unit, National Centre for Rare Skin Disorders, H\u00f4pital Pellegrin-Enfants, CHU de Bordeaux, Bordeaux, F-33000, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Dermatology unit, National Centre for Rare Skin Disorders, H\u00f4pital Pellegrin-Enfants, CHU de Bordeaux, Bordeaux, F-33000, France","institution_ids":["https://openalex.org/I3018323443","https://openalex.org/I4210112727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088413919","display_name":"Jo\u00ebl Schlatter","orcid":"https://orcid.org/0000-0002-4443-8843","observed_orcids":["https://orcid.org/0000-0002-4443-8843"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jo\u00ebl Schlatter","raw_affiliation_strings":["Department of Pharmacy, H\u00f4pital Universitaire Necker-Enfants Malades, Paris, F-75006, France"],"raw_orcid":"https://orcid.org/0000-0002-4443-8843","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, H\u00f4pital Universitaire Necker-Enfants Malades, Paris, F-75006, France","institution_ids":["https://openalex.org/I1288880153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047941451","display_name":"Fanny Morice\u2010Picard","orcid":"https://orcid.org/0000-0002-4316-916X","observed_orcids":["https://orcid.org/0000-0002-4316-916X"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]},{"id":"https://openalex.org/I4210112727","display_name":"H\u00f4pital Pellegrin","ror":"https://ror.org/02x581406","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443","https://openalex.org/I4210112727"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fanny Morice-Picard","raw_affiliation_strings":["Pediatric Dermatology unit, National Centre for Rare Skin Disorders, H\u00f4pital Pellegrin-Enfants, CHU de Bordeaux, Bordeaux, F-33000, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Dermatology unit, National Centre for Rare Skin Disorders, H\u00f4pital Pellegrin-Enfants, CHU de Bordeaux, Bordeaux, F-33000, France","institution_ids":["https://openalex.org/I3018323443","https://openalex.org/I4210112727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080332595","display_name":"Stefano Sol","orcid":"https://orcid.org/0000-0003-2576-0156","observed_orcids":["https://orcid.org/0000-0003-2576-0156"]},"institutions":[{"id":"https://openalex.org/I4210128854","display_name":"CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)","ror":"https://ror.org/033pa2k60","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210128854"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefano Sol","raw_affiliation_strings":["CEINGE, Napoli, Italy","University of Naples Federico II, Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEINGE, Napoli, Italy","institution_ids":["https://openalex.org/I4210128854"]},{"raw_affiliation_string":"University of Naples Federico II, Napoli, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064465434","display_name":"Christine Bodemer","orcid":"https://orcid.org/0000-0001-8772-0905","observed_orcids":["https://orcid.org/0000-0001-8772-0905","https://orcid.org/0000-0002-3089-5744"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210086369","display_name":"Institut Necker Enfants Malades","ror":"https://ror.org/000nhq538","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210086369","https://openalex.org/I4210096427"]},{"id":"https://openalex.org/I4210165077","display_name":"Institut des Maladies G\u00e9n\u00e9tiques Imagine","ror":"https://ror.org/05rq3rb55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210100892","https://openalex.org/I4210165077"]},{"id":"https://openalex.org/I4387154652","display_name":"Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie","ror":"https://ror.org/05wzabs02","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154652"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christine Bodemer","raw_affiliation_strings":["Department of Dermatology and Reference center for Genodermatoses and Rare Skin Diseases (MAGEC), Paris, F-75006, France","Institut Imagine, H\u00f4pital Universitaire Necker-Enfants Malades, APHP5, Paris, F-75006, France","Universit\u00e9 Paris Centre, INSERM U1144, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Reference center for Genodermatoses and Rare Skin Diseases (MAGEC), Paris, F-75006, France","institution_ids":[]},{"raw_affiliation_string":"Institut Imagine, H\u00f4pital Universitaire Necker-Enfants Malades, APHP5, Paris, F-75006, France","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I4210086369","https://openalex.org/I4210165077"]},{"raw_affiliation_string":"Universit\u00e9 Paris Centre, INSERM U1144, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031910126","display_name":"Caterina Missero","orcid":"https://orcid.org/0000-0003-0905-5123","observed_orcids":["https://orcid.org/0000-0003-0905-5123"]},"institutions":[{"id":"https://openalex.org/I4210128854","display_name":"CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)","ror":"https://ror.org/033pa2k60","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210128854"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Caterina Missero","raw_affiliation_strings":["CEINGE, Napoli, Italy","University of Naples Federico II, Napoli, Italy"],"raw_orcid":"https://orcid.org/0000-0003-0905-5123","affiliations":[{"raw_affiliation_string":"CEINGE, Napoli, Italy","institution_ids":["https://openalex.org/I4210128854"]},{"raw_affiliation_string":"University of Naples Federico II, Napoli, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061052754","display_name":"Salvatore Cisternino","orcid":"https://orcid.org/0000-0001-8500-3574","observed_orcids":["https://orcid.org/0000-0001-8500-3574"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387154652","display_name":"Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie","ror":"https://ror.org/05wzabs02","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154652"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Salvatore Cisternino","raw_affiliation_strings":["Department of Pharmacy, H\u00f4pital Universitaire Necker-Enfants Malades, Paris, F-75006, France","Facult\u00e9 de Pharmacie de Paris, INSERM U1144, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, H\u00f4pital Universitaire Necker-Enfants Malades, Paris, F-75006, France","institution_ids":["https://openalex.org/I1288880153"]},{"raw_affiliation_string":"Facult\u00e9 de Pharmacie de Paris, INSERM U1144, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067924168","display_name":"Daniel Aberdam","orcid":"https://orcid.org/0000-0002-4019-5418","observed_orcids":["https://orcid.org/0000-0002-4019-5418"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]},{"id":"https://openalex.org/I4387154437","display_name":"HIPI -  Immunologie humaine, physiopathologie et immunith\u00e9rapie","ror":"https://ror.org/008e1sp22","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154437"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Daniel Aberdam","raw_affiliation_strings":["INSERM U976, Paris, France. daniel.aberdam@inserm.fr","Universit\u00e9 Paris-Diderot, Paris, France. daniel.aberdam@inserm.fr","Universit\u00e9 Paris-Diderot, Paris, France"],"raw_orcid":"https://orcid.org/0000-0002-4019-5418","affiliations":[{"raw_affiliation_string":"INSERM U976, Paris, France. daniel.aberdam@inserm.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154437"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Diderot, Paris, France. daniel.aberdam@inserm.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154366"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Diderot, Paris, France","institution_ids":["https://openalex.org/I4387154366"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076354395","display_name":"Smail Hadj-Rabia","orcid":"https://orcid.org/0000-0001-6801-7106","observed_orcids":["https://orcid.org/0000-0001-6801-7106"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210086369","display_name":"Institut Necker Enfants Malades","ror":"https://ror.org/000nhq538","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210086369","https://openalex.org/I4210096427"]},{"id":"https://openalex.org/I4210165077","display_name":"Institut des Maladies G\u00e9n\u00e9tiques Imagine","ror":"https://ror.org/05rq3rb55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210100892","https://openalex.org/I4210165077"]},{"id":"https://openalex.org/I4387154652","display_name":"Optimisation Th\u00e9rapeutique en Neuropsychopharmacologie","ror":"https://ror.org/05wzabs02","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154652"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Smail Hadj-Rabia","raw_affiliation_strings":["Department of Dermatology and Reference center for Genodermatoses and Rare Skin Diseases (MAGEC), Paris, F-75006, France. smail.hadj@inserm.fr","Institut Imagine, H\u00f4pital Universitaire Necker-Enfants Malades, APHP5, Paris, F-75006, France. smail.hadj@inserm.fr","Universit\u00e9 Paris Centre, INSERM U1144, Paris, France. smail.hadj@inserm.fr","Department of Dermatology and Reference center for Genodermatoses and Rare Skin Diseases (MAGEC), Paris, F-75006, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Reference center for Genodermatoses and Rare Skin Diseases (MAGEC), Paris, F-75006, France. smail.hadj@inserm.fr","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Institut Imagine, H\u00f4pital Universitaire Necker-Enfants Malades, APHP5, Paris, F-75006, France. smail.hadj@inserm.fr","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I154526488","https://openalex.org/I4210086369","https://openalex.org/I4210165077"]},{"raw_affiliation_string":"Universit\u00e9 Paris Centre, INSERM U1144, Paris, France. smail.hadj@inserm.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154652"]},{"raw_affiliation_string":"Department of Dermatology and Reference center for Genodermatoses and Rare Skin Diseases (MAGEC), Paris, F-75006, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5067924168","https://openalex.org/A5076354395"],"corresponding_institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I154526488","https://openalex.org/I4210086369","https://openalex.org/I4210165077","https://openalex.org/I4387154366","https://openalex.org/I4387154437","https://openalex.org/I4387154652"],"apc_list":{"value":3990,"currency":"USD","value_usd":3990},"apc_paid":{"value":3990,"currency":"USD","value_usd":3990},"fwci":2.3611,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.89021283,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"11","issue":"1","first_page":"30","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12355","display_name":"Genetic and rare skin diseases.","score":0.3707999885082245,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12355","display_name":"Genetic and rare skin diseases.","score":0.3707999885082245,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11650","display_name":"Skin and Cellular Biology Research","score":0.298799991607666,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11919","display_name":"dental development and anomalies","score":0.27320000529289246,"subfield":{"id":"https://openalex.org/subfields/3500","display_name":"General Dentistry"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aplasia-cutis-congenita","display_name":"aplasia cutis congenita","score":0.8130000233650208},{"id":"https://openalex.org/keywords/prima-1met","display_name":"PRIMA-1MET","score":0.9430000185966492},{"id":"https://openalex.org/keywords/apr-246","display_name":"APR-246","score":0.9980000257492065},{"id":"https://openalex.org/keywords/p53-reactivation","display_name":"p53 reactivation","score":0.7250000238418579},{"id":"https://openalex.org/keywords/epidermal-differentiation","display_name":"epidermal differentiation","score":0.7820000052452087},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.8379999995231628},{"id":"https://openalex.org/keywords/skin-erosion","display_name":"skin erosion","score":0.796999990940094},{"id":"https://openalex.org/keywords/topical-cream","display_name":"topical cream","score":0.5189999938011169},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.7950000166893005},{"id":"https://openalex.org/keywords/re-epithelialization","display_name":"re-epithelialization","score":0.8550000190734863},{"id":"https://openalex.org/keywords/p73","display_name":"p73","score":0.875}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.398796021938324},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3386751711368561}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002454","descriptor_name":"Cell Differentiation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004476","descriptor_name":"Ectodermal Dysplasia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004476","descriptor_name":"Ectodermal Dysplasia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004476","descriptor_name":"Ectodermal Dysplasia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D004817","descriptor_name":"Epidermis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011812","descriptor_name":"Quinuclidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011812","descriptor_name":"Quinuclidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011812","descriptor_name":"Quinuclidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D025521","descriptor_name":"Tumor Suppressor Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D066329","descriptor_name":"Protein Aggregates","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/s41419-020-2223-8","doi":"https://doi.org/10.1038/s41419-020-2223-8","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41419-020-2223-8","pdf_url":"https://www.nature.com/articles/s41419-020-2223-8.pdf","source":{"id":"https://openalex.org/S185208586","display_name":"Cell Death and Disease","issn_l":"2041-4889","issn":["2041-4889"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Death & Disease","raw_type":"journal-article"},{"id":"pmid:31949132","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31949132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell death & disease","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6965199","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6965199/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Death Dis","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:56709a8c9acb4a36af38d990ea334bf7","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/56709a8c9acb4a36af38d990ea334bf7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cell Death and Disease, Vol 11, Iss 1, Pp 1-7 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41419-020-2223-8","doi":"https://doi.org/10.1038/s41419-020-2223-8","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41419-020-2223-8","pdf_url":"https://www.nature.com/articles/s41419-020-2223-8.pdf","source":{"id":"https://openalex.org/S185208586","display_name":"Cell Death and Disease","issn_l":"2041-4889","issn":["2041-4889"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Death & Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1426462793","display_name":null,"funder_award_id":"GGP16235","funder_id":"https://openalex.org/F4320321179","funder_display_name":"Fondazione Telethon"}],"funders":[{"id":"https://openalex.org/F4320320883","display_name":"Agence Nationale de la Recherche","ror":"https://ror.org/00rbzpz17"},{"id":"https://openalex.org/F4320320893","display_name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","ror":"https://ror.org/02vjkv261"},{"id":"https://openalex.org/F4320321179","display_name":"Fondazione Telethon","ror":"https://ror.org/04xraxn18"},{"id":"https://openalex.org/F4320323491","display_name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie et de Pathologie Sexuellement Transmissible","ror":"https://ror.org/03gck1m55"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2999588368.pdf","grobid_xml":"https://content.openalex.org/works/W2999588368.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1980943360","https://openalex.org/W1989190896","https://openalex.org/W1991738304","https://openalex.org/W2000854021","https://openalex.org/W2006773272","https://openalex.org/W2010807493","https://openalex.org/W2031822272","https://openalex.org/W2038977882","https://openalex.org/W2073625860","https://openalex.org/W2093202404","https://openalex.org/W2120437924","https://openalex.org/W2132402780","https://openalex.org/W2137303628","https://openalex.org/W2782869095","https://openalex.org/W2907307161"],"related_works":["https://openalex.org/W3205766521","https://openalex.org/W2061074820","https://openalex.org/W2120437924","https://openalex.org/W2042605456","https://openalex.org/W4411677910","https://openalex.org/W2177429081","https://openalex.org/W2041338838","https://openalex.org/W2968269707","https://openalex.org/W2978481020","https://openalex.org/W3153601080"],"abstract_inverted_index":{"Abstract":[0],"P63":[1,24,93],"is":[2,25],"a":[3,114,195,229,245,293],"major":[4],"transcription":[5],"factor":[6],"regulating":[7],"skin":[8,76,145,227,298],"development":[9],"and":[10,21,42,53,67,122,140,151,164,208,228,257,275],"homeostasis.":[11],"It":[12,187],"controls":[13],"many":[14,60],"genes":[15],"involved":[16],"in":[17,27,125],"cell":[18,267,273],"proliferation,":[19],"adhesion,":[20],"early":[22],"differentiation.":[23],"mutated":[26],"several":[28],"rare":[29],"syndromes":[30,35,44],"called":[31,117],"p63-related":[32],"ectodermal":[33,68],"dysplasia":[34],"(ED).":[36],"The":[37],"main":[38],"forms":[39],"are":[40],"EEC":[41],"AEC":[43,71,137,175,297],"due":[45],"to":[46,95,190],"p63":[47,243,256,277],"missense":[48,157],"mutations":[49,158],"on":[50,159,201,209],"the":[51,96,160,192,202,210,213,219,225,250,287],"DBD":[52],"SAM":[54,161],"domains,":[55],"respectively.":[56,153],"ED":[57],"patients":[58,72,155,176],"display":[59,89],"developmental":[61],"defects,":[62],"including":[63],"ectrodactyly,":[64],"clef/lip":[65],"palate,":[66],"dysplasia,":[69],"while":[70,265],"suffer":[73],"from":[74,135,143,173],"severe":[75],"erosions":[77,146],"that":[78,86,106,168,181,197,270,284],"not":[79,261,276],"always":[80],"heal.":[81],"We":[82,104,166],"have":[83],"previously":[84],"showed":[85],"ED-derived":[87],"iPSC":[88],"altered":[90,178],"epidermal":[91,108,133,179],"commitment.":[92],"belongs":[94],"p53":[97],"gene":[98],"family":[99],"sharing":[100],"similar":[101],"structural":[102],"domains.":[103],"found":[105,167],"ED-iPSC":[107],"commitment":[109],"can":[110],"be":[111],"rescued":[112,183],"by":[113,184],"p53-reactivating":[115],"compounds":[116],"PRIMA-1MET,":[118],"also":[119],"named":[120],"APR-246":[121],"currently":[123],"used":[124],"anticancer":[126],"clinical":[127],"trials.":[128],"Here,":[129],"we":[130,282],"established":[131],"primary":[132,169],"culture":[134],"two":[136],"children":[138],"(S.F.":[139],"Y.M.)":[141],"suffering":[142],"persistent":[144],"at":[147],"age":[148],"of":[149,205,212,224,232,239,252,286,296],"9":[150],"15,":[152],"These":[154],"carry":[156],"domain":[162],"(I576T":[163],"I537T).":[165],"keratinocytes":[170],"(KCs)":[171],"isolated":[172],"these":[174],"underwent":[177],"differentiation":[180,274],"was":[182,198],"PRIMA-1MET":[185,259,271,289],"treatment.":[186],"prompted":[188],"us":[189],"formulate":[191],"compound":[193,290],"onto":[194],"cream":[196],"topically":[199],"applied":[200],"right":[203],"hand":[204],"one":[206],"patient":[207],"scalp":[211],"second":[214],"patient.":[215],"In":[216,280],"both":[217],"cases,":[218],"daily":[220],"treatment":[221,295],"allowed":[222],"re-epithelialization":[223],"eroded":[226],"drastic":[230],"loss":[231],"pain":[233],"after":[234],"few":[235],"weeks,":[236],"improving":[237],"quality":[238],"life.":[240],"Normally,":[241],"mutant":[242],"exerts":[244],"dominant-negative":[246],"effect,":[247],"mainly":[248],"through":[249],"formation":[251],"aggregate":[253],"with":[254],"WT":[255],"p73.":[258],"did":[260],"reduce":[262],"protein":[263],"aggregation":[264],"enhancing":[266],"differentiation,":[268],"suggesting":[269],"targets":[272],"activity":[278],"directly.":[279],"conclusion,":[281],"propose":[283],"repurposing":[285],"antitumoral":[288],"could":[291],"become":[292],"general":[294],"erosions.":[299]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-01-23T00:00:00"}